Life sciences
R&D performance improvement
All pharmaceutical executives are concerned to maximise the value that R&D can add and most companies are undertaking R&D performance improvement initiatives.
However success in these initiatives faces these challenges:
- the long timescales of R&D
- differences between the preferred conduct of different projects and therapy areas (for example, differences in acceptable clinical and commercial risk)
- subjective criteria for agreement on performance in a creative, high-risk environment (is repeated fast failure good, or a predictor that a team can never succeed?)
- the fact that few pharmaceutical R&D project managers have the chance to experience both failure and success in their careers, so cannot effectively learn without help envisaging the possible consequences of planned actions for various scenarios.
PA's expertise in change management and quantitative performance modelling offers three main services for such projects:
- a proven change management framework that encourages early agreement and clear communication on the business goals and change imperatives (maximum benefit vs minimal risk vs permanence vs speed of change)
- pre-built and tailored simulations of R&D processes and decisions at a number of levels, that can help decision-makers develop consistent and sound mental models (portfolio, throughput, quality, time-and-effect, system dynamics, decision analysis and multi-criteria models, and tailored combinations of these, including a unique patented approach to optimising the resources applied to reducing controllable risks - which we call ARBITER)
- independent and dedicated, scientifically literate effort to help make the case for change, design the change in detail, help define the communication plan, and support the client team as needed in delivery.
Further information
For further information please e-mail: healthcare@paconsulting.com
|
